Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Bermel

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
The Lancet. Neurology|September 19, 2017
Unravelling neurodegeneration in multiple sclerosisRobert A Bermel
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 16, 2021
DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity - NoRobert A Bermel
The Lancet. Neurology|January 24, 2006
The measurement and clinical relevance of brain atrophy in multiple sclerosisRobert A Bermel, Rohit Bakshi
Neurology|December 26, 2012
Neurodegeneration and inflammation in MS: the eye teaches us about the stormRobert A Bermel, Matilde Inglese
Neurology(R) Neuroimmunology & Neuroinflammation|April 13, 2021
The Calm Between Storms: Serum Biomarkers in Assessing Interattack Astrocytopathy in Neuromyelitis Optica Spectrum DisorderCarolyn Goldschmidt, Robert A Bermel
Neurology|May 20, 2014
Retrograde trans-synaptic degeneration in MS: a missing link?Robert A Bermel, Pablo Villoslada
Neurology|July 13, 2011
Fulminant cerebral demyelination in neuromyelitis opticaChristopher R Newey, Robert A Bermel
Current Opinion in Neurology|April 19, 2015
Using MRI to make informed clinical decisions in multiple sclerosis careRobert A Bermel, Robert T Naismith
Continuum (Minneapolis, Minn.)|July 20, 2012
MRI in multiple sclerosisRobert A Bermel, Robert J Fox
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Interferon-beta treatment for multiple sclerosisRobert A Bermel, Richard A Rudick
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
The Lancet. Neurology|September 19, 2017
Unravelling neurodegeneration in multiple sclerosisRobert A Bermel
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 16, 2021
DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity - NoRobert A Bermel
The Lancet. Neurology|January 24, 2006
The measurement and clinical relevance of brain atrophy in multiple sclerosisRobert A Bermel, Rohit Bakshi
Neurology|December 26, 2012
Neurodegeneration and inflammation in MS: the eye teaches us about the stormRobert A Bermel, Matilde Inglese
Neurology(R) Neuroimmunology & Neuroinflammation|April 13, 2021
The Calm Between Storms: Serum Biomarkers in Assessing Interattack Astrocytopathy in Neuromyelitis Optica Spectrum DisorderCarolyn Goldschmidt, Robert A Bermel
Neurology|May 20, 2014
Retrograde trans-synaptic degeneration in MS: a missing link?Robert A Bermel, Pablo Villoslada
Neurology|July 13, 2011
Fulminant cerebral demyelination in neuromyelitis opticaChristopher R Newey, Robert A Bermel
Current Opinion in Neurology|April 19, 2015
Using MRI to make informed clinical decisions in multiple sclerosis careRobert A Bermel, Robert T Naismith
Continuum (Minneapolis, Minn.)|July 20, 2012
MRI in multiple sclerosisRobert A Bermel, Robert J Fox
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Interferon-beta treatment for multiple sclerosisRobert A Bermel, Richard A Rudick
Pageof 8